Women Scientists Fighting for Men
Women scientists across the country are fighting to find a cure for prostate cancer and help cancer patients live better lives. Here are a few of their stories:
Dr. Padmanee Sharma of the University of Texas MD Anderson Cancer Center is a medical oncologist and immunologist. PCF provided her first grant through the Young Investigators program, which started her career in prostate cancer research. Sharma focuses on how immunotherapy can be used in prostate cancer treatment. She uses reverse translation to craft new clinical trials based on the data gathered during previous trials. Sharma believes that immunotherapy breakthroughs have the potential to affect all types of cancer, not just prostate cancer.
Dr. Stacey Loeb is a urologist and prostate cancer researcher at New York University. Her area of focus is on analyzing and improving the cancer screening process. While screening saves lives, problems in the screening process can result in overdiagnosis and overtreatment. Loeb focuses on new practices like active surveillance that will improve the screening process in the future. In addition to her screening research, Loeb is interested in how digital and social media can be used to enhance patient communication and further cancer research.
Dr. Charlotte Bevan, a professor in cancer biology at Imperial College London, is engaged in research into precision medicine, which focuses on determining which patients will benefit from which therapies. She studies the impact of hormones in prostate cancer and is investigating biomarkers for prostate cancer. She sees precision medicine as the biggest upcoming breakthrough in cancer research and is excited that prostate cancer researchers are at the forefront of this movement.
Dr. Claire Fletcher, a molecular biologist at Imperial College London, is studying microRNAs, small pieces of genetic material that may help doctors determine which men will respond well to specific prostate cancer treatments. She is a recipient of one of PCF’s Young Investigators Awards and believes that PCF’s focus on funding interdisciplinary projects will result in innovative new ideas that bring scientists closer to a cure.
Dr. Alicia Morgans is a medical oncologist at the Vanderbilt University School of Medicine, where she treats patients and researches the long-term effects of prostate cancer treatment on survivors. Some long-term survivors experience pain and a poor quality of life, and Morgans is driven by a desire to improve the lives of these patients. She hopes to eliminate the complications of advanced prostate cancer and ensure that the treatment doesn’t feel worse than the disease.
PCF is deeply invested in the careers of these researchers, as well as many other women who are contributing to advancements in prostate cancer screening, treatment, and research. Together we can find a cure for prostate cancer.